Vaccine rollout begins around the world
The story first appeared in The Times of Bennett, a student-led newspaper of the Times School of Media
By Varun Kheria
MANCHESTER, UK:Vaccines for the COVID-19 virus have started to be rolled out to the public in parts of the world, one of them being the Oxford-AstraZeneca vaccine that was recently approved by United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA). Alex Thomas, a 21-year-old guy talks about his experience after he got vaccinated.
Alex thought that the process of vaccination was handled very well by the UK government, he got a call on the 15th of January and was told that his vaccination had been scheduled a week from then. “From the car park to the door, door to reception, reception to the vaccine room, the vaccine room to the exit. It was really well planned and there was no waiting around”, he said “it was all super-efficient. There was a purpose to every second. Like there was 2 doctors in the vaccine room, one to do the paperwork and the other to read you the generic questions or 'are you allergic to etc...' and give the vaccine.”
Though the process of vaccination went really smoothly, the side effects of it were worse than he had anticipated. “The first side effects were typical of vaccines- soreness around the jab site, but a few hours later, I got a headache and chills. Then muscle ache and nausea the next day.” Unfortunately, because of being one of the first to get the vaccine, he doesn’t know anyone else who has had it, so we don't know if anyone is getting the same side effects as him, or to the same degree.
India's drug regulator has given the green light to Covishield (the local name for the Oxford-AstraZeneca vaccine) andCovaxin , made by Bharat Biotech . It would be interesting to see if after seeing the side-effects that the vaccine is having on those who have been given it already, how the plans of its distribution in India will be affected.
There is another thing that needs to be kept in mind while delivering the vaccine, taking it once isn’t enough to develop an immunity toCOVID . “The government added the rule that people who've had the first dose of the vaccine have to wait up to 12 weeks for their second dose, which goes against the doctor’s recommendations of 3 weeks. I feel like they only care about saying how many people they've vaccinated, rather than how many people now have immunity. But there's not much point in having 50 million people with the first vaccine if those 50 million haven't had the second dose and aren't immune yet” says Alex. This is a critical factor keeping in mind that India has a population of over a billion people and it might mean that the lockdown might have to be enforced until the second dose of the vaccines start rolling out to avoid more deaths from this virus.
(The writer is a first-year student of BA (Journalism and Mass Communication) of The Times School of Media)
Join exciting programmes offered by Bennett University
By Varun Kheria
MANCHESTER, UK:
Alex thought that the process of vaccination was handled very well by the UK government, he got a call on the 15th of January and was told that his vaccination had been scheduled a week from then. “From the car park to the door, door to reception, reception to the vaccine room, the vaccine room to the exit. It was really well planned and there was no waiting around”, he said “it was all super-efficient. There was a purpose to every second. Like there was 2 doctors in the vaccine room, one to do the paperwork and the other to read you the generic questions or 'are you allergic to etc...' and give the vaccine.”
Though the process of vaccination went really smoothly, the side effects of it were worse than he had anticipated. “The first side effects were typical of vaccines- soreness around the jab site, but a few hours later, I got a headache and chills. Then muscle ache and nausea the next day.” Unfortunately, because of being one of the first to get the vaccine, he doesn’t know anyone else who has had it, so we don't know if anyone is getting the same side effects as him, or to the same degree.
India's drug regulator has given the green light to Covishield (the local name for the Oxford-AstraZeneca vaccine) and
There is another thing that needs to be kept in mind while delivering the vaccine, taking it once isn’t enough to develop an immunity to
(The writer is a first-year student of BA (Journalism and Mass Communication) of The Times School of Media)
Join exciting programmes offered by Bennett University
Recent Messages ()
Please rate before posting your Review
SIGN IN WITH
Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil.